- Two of the bills would allow the states to act on the information, not just require disclosure. Pennsylvania’s would allow insurers to refuse to pay for a drug if the manufacturer did not file the required report.
I found the passage above to be kind of eerie. Pharmaceuticals are increasingly getting expensive, yet in the article they never really mention the effect this has on the people taking the drugs. The passage above says that insurance could refuse to pay for a drug if the company didn't file the required reports, and what happens to the patient who may need the medicine in that scenario? Working in a local pharmacy you see the prices just go up and up without any real reasoning behind it.
Sounds about right honestly. Pharmaceuticals literally give no reason for raising their prices. They say development costs, but like the article says even older drugs can get a price change. Some of these pharmaceutical companies are making the brand name and the generic. It's crazy that they have such a monopoly on such a life-saving market.